FIELD: medicine, medicinal preparations, pharmacy.
SUBSTANCE: invention proposes a new complex comprising at least one substance taken among the group: osteoclastogenesis-inhibitory factor (OCIF), its analogues and its variants that are bound with a substance taken among the group consisting of polysaccharides and their derivatives. The complex exhibits property for prolonged retention in blood stream after its administration that provides its applicability in treatment and prophylaxis of osseous metabolic diseases. The complex provides normalization of osseous metabolism.
EFFECT: valuable medicinal properties of complex, expanded assortment of agents.
34 cl, 8 tbl, 8 ex
| Title |
Year |
Author |
Number |
| AGENT FOR TREATMENT OF PATHOLOGICAL OSSEOUS METABOLISM |
1999 |
- Motizuki Siniti
- Fudzise Nobuaki
- Masujama Tikharu
- Tsuda Eisuke
- Khigasio Kandzi
|
RU2223782C2 |
| PROTEIN ABLE TO INHIBIT OSTEOCLASTOGENESIS (OCIF) (VARIANTS), CDNA, METHOD FOR PREPARING PROTEIN, METHOD FOR TREATMENT OF OSTEOPOROSIS, METHOD FOR TREATMENT AND/OR IMPROVEMENT OF BONE MASS RECOVERY, METHOD FOR TREATMENT OF INJURE ASSOCIATED WITH OSSEOUS METABOLISM, TRANSFORMED STRAIN ESCHERICHIA COLI PBK/01F10 AND PHARMACEUTICAL COMPOSITION |
1996 |
- Goto Masaaki
- Tsuda Ehjsuke
- Motizuki Siniti
- Jano Kazuki
- Kobajasi Fumie
- Sima Nobujuki
- Jasuda Khisataka
- Nakagava Nobuaki
- Morinaga Tomonori
- Ueda Masatsugu
- Khigasio Kandzi
|
RU2238948C2 |
| NOVEL PROTEINS AND METHODS OF THEIR PREPARING |
1996 |
- Goto Masaaki
- Tsuda Ehjsuke
- Motizuki Siniti
- Jano Kazuki
- Kobajasi Fumie
- Sima Nobujuki
- Jasuda Khisataka
- Nakagava Nobuaki
- Morinaga Tomonori
- Ueda Masatsugu
- Khigasio Kandzi
|
RU2194714C2 |
| POLYMERIC MODIFYING AGENTS AND PHARMACEUTICAL COMPOSITIONS |
2004 |
- Kasuja Judzi
- Khonma Masasi
|
RU2323227C2 |
| METHOD OF FINDING OF POLYVALENT ANTIGEN IN BIOLOGICAL FLUID |
1989 |
- Khel'Mut Lents[De]
- Ehllen Messner[De]
- Verner Shtok[De]
- Norbert Franken[De]
- Robert Krehns Makkarti[Us]
- Al'Bert Reder[De]
- Kharal'D Khaug[De]
|
RU2032906C1 |
| METHOD OF DESTROYING CELLS USING EFFECTOR FUNCTIONS OF ANTI-EphA4 ANTIBODIES |
2007 |
- Nakatsuru Suiti
- Josikava Megumi
- Khirosima Siniti
- Kisi Josiro
- Kukhara Motoki
- Nisida Sijo
- Sinokhara Midori
|
RU2429246C2 |
| ANTIBODY DIRECTED ON SIGLEC-15 PROTEIN, BOUND WITH OSTEOCLASTS |
2008 |
- Khiruma Josikharu
- Tsuda Ejsuke
|
RU2475499C2 |
| GLAUCOMA TREATMENT |
2018 |
|
RU2759998C2 |
| ANTIGEN-BINDING MOLECULE, ABLE TO MULTIPLELY CONTACT WITH PLURALITY OF ANTIGENIC MOLECULES |
2011 |
- Igava Tomoyuki
- Isii Sinya
- Funaki Mikho
- Khironiva Naoka
- Maeda Atsukhiko
- Nezu Dzuniti
- Ruike Esinao
- Baba Takesi
- Simizu Sun
|
RU2642318C2 |
| PROTEIN BINDING SPECIFICALLY WITH OSTEOCLASTOGENESIS-INHIBITING FACTOR (OCIF) (VARIANTS), DNA ENCODING ITS (VARIANTS), DNA AS PROBE (VARIANTS), METHOD FOR PREPARING PROTEIN (VARIANTS), METHOD FOR SCREENING SUBSTANCE (VARIANTS), ANTIBODY (VARIANTS), METHOD FOR PREPARING POLYCLONAL ANTIBODY, HYBRIDOMA (VARIANTS), METHOD FOR PREPARING MONOCLONAL ANTIBODY, METHOD FOR ASSAY OF OCIF-BINDING PROTEIN, PHARMACEUTICAL COMPOSITION (VARIANTS) AND MEDICINAL AGENT (VARIANTS) |
1998 |
- Jamaguti Kiodzi
- Jasuda Khisataka
- Nakagava Nobuaki
- Sima Nobujuki
- Kinosaki Masakhiko
- Tsuda Eisuke
- Goto Masaaki
- Jano Kazuki
- Tomojasu Akikhiro
- Kobajasi Fumie
- Vasida Naokhiro
- Takakhasi Ken
- Morinaga Tomonori
- Khigasio Kandzi
|
RU2238949C2 |
